Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Arcutis Biotherapeutics, Inc. Common Stock | ARQT

AI Analysis of Arcutis Biotherapeutics, Inc. Common Stock

Arcutis Biotherapeutics saw some selling pressure today and moved down -4.20%

Currently ARQT isn't at a clear support/resistance line that seems tradable. Momentum wise Arcutis Biotherapeutics, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. ARQT might find some support at the 29.9 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-